Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.

× No keyword cloud information.

43 in total

1. A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients.

Authors: Su-Jun Lee; Yin Jin Jang; Eun-Young Cha; Ho-Sook Kim; Sang Seop Lee; Jae-Gook Shin
Journal: Br J Clin Pharmacol Date: 2010-08 Impact factor: 4.335

Review 2. Rate and extent of drug accumulation after multiple dosing revisited.

Authors: Dion R Brocks; Reza Mehvar
Journal: Clin Pharmacokinet Date: 2010-07 Impact factor: 6.447

Review 3. Pharmacogenetics of target genes across the warfarin pharmacological pathway.

Authors: Suman Lal; Srinivasa Rao Jada; Xiaoqiang Xiang; Wan-Teck Lim; Edmund J D Lee; Balram Chowbay
Journal: Clin Pharmacokinet Date: 2006 Impact factor: 6.447

Review 4. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors: K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal: Clin Pharmacokinet Date: 2000-02 Impact factor: 6.447

5. Pharmacogenetics of epilepsy: one step forward?

Authors: Graeme J Sills
Journal: Epilepsy Curr Date: 2005 Nov-Dec Impact factor: 7.500

6. Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.

Authors: Hayley S Brown; Kiyomi Ito; Aleksandra Galetin; J Brian Houston
Journal: Br J Clin Pharmacol Date: 2005-11 Impact factor: 4.335

Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.

1. A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients.

Review 2. Rate and extent of drug accumulation after multiple dosing revisited.

Review 3. Pharmacogenetics of target genes across the warfarin pharmacological pathway.

Review 4. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

5. Pharmacogenetics of epilepsy: one step forward?

6. Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.

Review 7. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.

Review 8. Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.

9. CYP isoform specificity toward drug metabolism: analysis using common feature hypothesis.

Review 10. Clinical significance of the cytochrome P450 2C19 genetic polymorphism.